中西医结合食管癌治疗方案专家共识(2021年版)

2021-02-20 中日友好医院学报.2021.35(1):3-7.

食管癌是我国常见的恶性肿瘤之一,属中医学之“噎膈”,近半个世纪我国食管癌中西医防治取得了丰硕成果。本项共识针对食管癌发生发展不同阶段,以食管癌筛查与预防、中医协同放化疗、晚期食

中文标题:

中西医结合食管癌治疗方案专家共识(2021年版)

发布机构:

发布日期:

2021-02-20

简要介绍:

食管癌是我国常见的恶性肿瘤之一,属中医学之“噎膈”,近半个世纪我国食管癌中西医防治取得了丰硕成果。本项共识针对食管癌发生发展不同阶段,以食管癌筛查与预防、中医协同放化疗、晚期食管癌中西医姑息治疗为切入点,结合中西医相关指南和临床研究成果,形成了4 项中西医结合食管癌治疗方案,供中西医临床肿瘤医师参考应用,提高我国食管癌防治水平。

相关资料下载:
[AttachmentFileName(sort=1, fileName=中西医结合食管癌治疗方案专家共识_2021年版_邓超.pdf)] GetToolGuiderByIdResponse(projectId=1, id=eca781c0020e36f3, title=中西医结合食管癌治疗方案专家共识(2021年版), enTitle=, guiderFrom=中日友好医院学报.2021.35(1):3-7., authorId=0, author=, summary=食管癌是我国常见的恶性肿瘤之一,属中医学之“噎膈”,近半个世纪我国食管癌中西医防治取得了丰硕成果。本项共识针对食管癌发生发展不同阶段,以食管癌筛查与预防、中医协同放化疗、晚期食, cover=https://img.medsci.cn/2021327/1616857469924_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Feb 20 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>食管癌是我国常见的恶性肿瘤之一,属中医学之&ldquo;噎膈&rdquo;,近半个世纪我国食管癌中西医防治取得了丰硕成果。本项共识针对食管癌发生发展不同阶段,以食管癌筛查与预防、中医协同放化疗、晚期食管癌中西医姑息治疗为切入点,结合中西医相关指南和临床研究成果,形成了4 项中西医结合食管癌治疗方案,供中西医临床肿瘤医师参考应用,提高我国食管癌防治水平。</p> </div> </div> </div>, tagList=[TagDto(tagId=751, tagName=食管癌)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=37, categoryName=中医科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=751, guiderKeyword=食管癌, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=21563, appHits=214, showAppHits=0, pcHits=944, showPcHits=21349, likes=4, shares=25, comments=11, approvalStatus=1, publishedTime=Sun Mar 28 00:59:20 CST 2021, publishedTimeString=2021-02-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sat Mar 27 23:04:45 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 00:25:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=中西医结合食管癌治疗方案专家共识_2021年版_邓超.pdf)])
中西医结合食管癌治疗方案专家共识_2021年版_邓超.pdf
下载请点击:
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1207079, encodeId=166a120e0795c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063158, encodeId=0b7b106315873, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Sat Oct 23 12:43:56 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056698, encodeId=aaf410566982d, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Fri Oct 01 07:41:24 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051813, encodeId=cefe1051813ba, content=谢谢,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f7f5607685, createdName=ms5000001955943678, createdTime=Thu Sep 16 09:37:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003064, encodeId=d10b10030643e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:00:42 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2022-03-30 56446_2968

    学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1207079, encodeId=166a120e0795c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063158, encodeId=0b7b106315873, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Sat Oct 23 12:43:56 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056698, encodeId=aaf410566982d, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Fri Oct 01 07:41:24 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051813, encodeId=cefe1051813ba, content=谢谢,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f7f5607685, createdName=ms5000001955943678, createdTime=Thu Sep 16 09:37:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003064, encodeId=d10b10030643e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:00:42 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-10-23 ms6000000578381996

    值得一看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1207079, encodeId=166a120e0795c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063158, encodeId=0b7b106315873, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Sat Oct 23 12:43:56 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056698, encodeId=aaf410566982d, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Fri Oct 01 07:41:24 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051813, encodeId=cefe1051813ba, content=谢谢,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f7f5607685, createdName=ms5000001955943678, createdTime=Thu Sep 16 09:37:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003064, encodeId=d10b10030643e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:00:42 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-10-01 ms6000000578381996

    谢谢分享,学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1207079, encodeId=166a120e0795c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063158, encodeId=0b7b106315873, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Sat Oct 23 12:43:56 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056698, encodeId=aaf410566982d, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Fri Oct 01 07:41:24 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051813, encodeId=cefe1051813ba, content=谢谢,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f7f5607685, createdName=ms5000001955943678, createdTime=Thu Sep 16 09:37:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003064, encodeId=d10b10030643e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:00:42 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-09-16 ms5000001955943678

    谢谢,很实用

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1207079, encodeId=166a120e0795c, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2ae16241095, createdName=56446_2968, createdTime=Wed Mar 30 05:38:19 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1063158, encodeId=0b7b106315873, content=值得一看, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Sat Oct 23 12:43:56 CST 2021, time=2021-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1056698, encodeId=aaf410566982d, content=谢谢分享,学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad535544361, createdName=ms6000000578381996, createdTime=Fri Oct 01 07:41:24 CST 2021, time=2021-10-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1051813, encodeId=cefe1051813ba, content=谢谢,很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6f7f5607685, createdName=ms5000001955943678, createdTime=Thu Sep 16 09:37:09 CST 2021, time=2021-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1003064, encodeId=d10b10030643e, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210803/18a80d2367814f61bbe4c923e65f1d98/16479f926d194fa8a9ea5e1f2e022e9b.jpg, createdBy=e1981971406, createdName=1e1606abm78(暂无匿称), createdTime=Tue Jul 27 18:00:42 CST 2021, time=2021-07-27, status=1, ipAttribution=)]
    2021-07-27 1e1606abm78(暂无匿称)

    很实用

    0

拓展阅读

2010ESMO临床实践指南:食管癌

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2010-05-01

食管癌规范化诊治指南

中国抗癌协会食管癌专业委员会(Chinese Society of Esophagenal Cancer, Chinese Anti-Cancer Association) · 2011-04-01

2011 AUGIS/BSG指南:食管癌与胃癌的处理

大不列颠爱尔兰上消化道外科医师协会(AUGIS,Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland) · 2011-07-24

2012 ASGE 内镜在Barrett食管及其他食管癌前病变中的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2012-12-01

2013 ASEG内镜在食管癌评估与治疗方面的作用

美国胃肠内镜学会(ASGE,American Society for Gastrointestinal Endoscopy) · 2013-03-01

2013 STS指南:食管癌患者的诊断与分期

美国胸外科医师学会(STS,Society of Thoracic Surgeons) · 2013-06-07